The Cigna Group's fundamentals are solid, but the stock is fairly valued versus peers, not a bargain. Click here to find out ...

Choosing the right specialty pharmacy partner is critical. Especially when you’re treating rare, chronic and complex ...

The global telehealth and telemedicine market is projected to grow at a CAGR of approximately 25% from 2024 to 2029. Key ...

Cigna Group is expected to release its fiscal second-quarter earnings later this month, and analysts project a single-digit ...

Browse 548 market data Tables and 65 Figures spread through 500 Pages and in-depth TOC on "Telehealth & Telemedicine Market ...

Walgreens Boots Alliance shareholders approved the company’s sale to private equity firm Sycamore Partners at a July 11 special meeting. Walgreens announced in March that it had entered into a $10 ...

Walgreens Boots Alliance shareholders have approved the company’s $10 billion acquisition by private equity firm Sycamore Partners during a special meeting held July 11. Here are four more notes to ...

GLP-1s drive a historic shift in traditional drug spending increases, outpacing specialty drug trends for the first time.

The Cigna Group is set to report its Q2 2025 earnings on July 31, with analysts expecting a 6.3% profit jump year-over-year.

Cigna’s stock presents a prime buying opportunity as it hovers at Fibonacci retracement support, underpinned by strong ...